Following five decades of progress against a heart attack, the US now now faces a huge increase in other deadly heart conditions, seeking immediate changes in public health focus and care.

Study: Heart disease mortality in the United States, 1970 to 2022Image Credit: Roman023_photography / Shutterstock

In a recent study at The Journal of the American Heart Association, researchers took advantage of five decades of heart data to highlight future clinical interventions and public health policy to highlight the sub -factories of long -term heart disease in the United States (US).

The findings of the study suggest that while the picture of the overall heart seems promising, 66% decrease in the overall age ingidelial heart disease mortality and acute myocardial infarction and ischemic cardiovascular disease due to significant decrease in mortality due to acute myocardial infarction and acute myocardial heart disease, other cardiovascular disease mortality, such as heart failure and high heart diseases. Dangerous, the mortality rate of arrhythmias demonstrated an increase of 450%, highlighting the need for our health systems and prepared for focusing our attention and for a wave of low-finished heart conditions in the US. The authors of the study note that some obvious growth in these conditions may reflect both real changes and improvements in clinical practices in decades.

It is necessary to accept that over time can be observed by changes in the disease classification and coding systems, including infections between ICD-8, ICD-9 and ICD-10 coding modifications, which can affect direct comparison in different decades. The author also takes precautions that some deaths for heart failure, arrhythmia, or cardiac arrest may be the underlying isteful reasons that are not completely occupied by death certificate data.

background

Heart diseases have retained their top position as the number one reason for annual human mortality in the United States (US) for more than a century. To combat this immense public health burden, the US government has implemented several policies aimed at reducing heart disease mortality, including increasing the number of coronary care units to the national number, starting a widespread smoking campaign and promoting training in communities, schools and workplaces.

With unprecedented technical and clinical progression, these implementation has reduced the sickness and mortality related to ischemic (coronary) heart disease. While widely recognized and celebrated within the scientific community, these cuts are rarely tested statistically and never used long -term trajectory data.

Recent evidence suggests that while the overall burden of heart disease mortality in the US may be on the decline, these observations are mainly due to the monitoring of the Ischemic Crime Disease (IHD) to the US and making major progress in treatment. In contrast, these publications reports have increased mortality from other heart conditions such as arrhythmia, heart failure and high blood pressure with heart disease.

About studies

The purpose of the present study is to address the gap of this knowledge and to inform the public health structure of the country by taking advantage of the government-complaints of more than fifty years, which provides a greater comprehensive picture of heart disease mortality from 1970 to 2022. Its purpose is to unlink the success rates of ischemic heart disease from the potentially serious picture arising from other heart conditions, where cardioocker medicine has been made available.

The 1970 study data through 2022 was obtained from the US Center for Disease Control and Prevention (CDC), which is an online data for epidemiological research (waster) database, is a deep compilation of demographic and medical information related to death for all dead American citizens. The current study limited the sample population to adults (25 years and older), with the diagnosis of heart disease associated with their condition. The cause of death was identified and recorded using international classification diseases (ICD-8, ICD-9, ICD-10) code.

The record of heart disease was classified: 1. Heart failure (i50), 2. Heart disease affected by high blood pressure (i11, i13), 3. Cardiomyopathy (I42), 4. Valvular heart disease (i34-i38), 5. Arrhythmia (i47-i49), and four other sub-availability. All analyzes were reported as a complete number per 100,000 cases, and all statistical models were adjusted for the demographic variables, especially for age. The Jyinpoint Rigress was used to plot a change (interval or overall) in the disease mortality rate over time, called a metric, called the ‘average annual percentage change (AAPC)’.

Study conclusion

The final study sample was about 230 million American adults in the Cohrort, more than double from the 1970s of 109 million. In this five decade period, Wonder Dataset reported 37 million heart deaths. The findings of the study shows two major points:

Meritive improvement in mortality associated with overall heart disease, arbitration of adequate decline in deaths mainly due to ischemic cardiovascular diseases. During the period between 1970 and 2022, acute myocardial infarction (AMI) mortality declined by 89%, chronic ischemic disease mortality declined by 71% and overall IHD mortality fell from an impressive 81% (AAPC -3.1%).

A hidden growth in other heart conditions. During the last 50 years, heart failure and high blood pressure with high blood pressure have increased the mortality rate of 146% and 106% respectively. The arrhythmia-related mortality has touched the sky up to 450% during the same period, as well as with a commendable increase in valvular, cardiomyopathy, pulmonary heart disease and the arrest of the heart. The study also found a significant decline in mortality from rheumatic heart disease during this period.

The authors visited a temporary spike in the heart disease mortality in 2020 during the Kovid -19 epidemic, but did not reverse the overall long -term bottom trend.

conclusion

The current study valid the overall decline in heart disease mortality in the US, while the country’s heart exposes a transfer balance in the environment. While ischemic heart disease contributes only to 53% of the US Cardiac Death toll (below 91% in 1970), non-Is Iskmic Substance 9% to 47% of the heart has died in the last five decades.

The expansion of future health strategies should be beyond coronary care to remove this emerging burden. The approach should include better monitoring, prevention and treatment of non-Iscemic heart conditions, especially among the population of aging. This study underlines the importance of research targeted to better understand the population differences in age, gender, breed/ethnicity and mortality by region, which was not fully ascertained in this analysis.